DK1287133T3 - Regulering af human dopamin-lignende G-protein-koblet receptor - Google Patents

Regulering af human dopamin-lignende G-protein-koblet receptor

Info

Publication number
DK1287133T3
DK1287133T3 DK01945139T DK01945139T DK1287133T3 DK 1287133 T3 DK1287133 T3 DK 1287133T3 DK 01945139 T DK01945139 T DK 01945139T DK 01945139 T DK01945139 T DK 01945139T DK 1287133 T3 DK1287133 T3 DK 1287133T3
Authority
DK
Denmark
Prior art keywords
protein
coupled receptor
regulation
human dopamine
obesity
Prior art date
Application number
DK01945139T
Other languages
Danish (da)
English (en)
Inventor
Shyam Ramakrishnan
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Application granted granted Critical
Publication of DK1287133T3 publication Critical patent/DK1287133T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK01945139T 2000-05-18 2001-05-16 Regulering af human dopamin-lignende G-protein-koblet receptor DK1287133T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20519500P 2000-05-18 2000-05-18
PCT/EP2001/005559 WO2001087929A2 (en) 2000-05-18 2001-05-16 Regulation of human dopamine-like g protein-coupled receptor

Publications (1)

Publication Number Publication Date
DK1287133T3 true DK1287133T3 (da) 2007-03-26

Family

ID=22761200

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01945139T DK1287133T3 (da) 2000-05-18 2001-05-16 Regulering af human dopamin-lignende G-protein-koblet receptor

Country Status (9)

Country Link
EP (1) EP1287133B1 (de)
AT (1) ATE348162T1 (de)
AU (1) AU6744501A (de)
CY (1) CY1105966T1 (de)
DE (1) DE60125169T2 (de)
DK (1) DK1287133T3 (de)
ES (1) ES2278755T3 (de)
PT (1) PT1287133E (de)
WO (1) WO2001087929A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030017528A1 (en) 1998-11-20 2003-01-23 Ruoping Chen Human orphan G protein-coupled receptors
US7816492B2 (en) 1998-11-20 2010-10-19 Arena Pharmaceuticals, Inc. Human G protein-coupled receptors
USRE42190E1 (en) 1998-11-20 2011-03-01 Arena Pharmaceuticals, Inc. Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors
EP1770159A1 (de) 2000-12-01 2007-04-04 Astellas Pharma Inc. Verfahren zur Herstellung eines Arzneimittels zur Behandlung von Diabetes
BRPI0406761A (pt) 2003-01-14 2005-12-20 Arena Pharm Inc Derivados de arila e heteroarila 1,2,3-trissubstituìdos como moduladores do metabolismo e a profilaxia e tratamento de distúrbios relacionados a estes tais como diabetes e hiper-glicemia
US7083933B1 (en) 2003-05-09 2006-08-01 Prosidion Limited Methods for identification of modulators of OSGPR116 activity
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
RS20060018A (en) 2003-07-14 2007-12-31 Arena Pharmaceuticals Inc., Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
DOP2006000008A (es) * 2005-01-10 2006-08-31 Arena Pharm Inc Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
MY148521A (en) 2005-01-10 2013-04-30 Arena Pharm Inc Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
DOP2006000010A (es) 2005-01-10 2006-07-31 Arena Pharm Inc Procedimiento para preparar eteres aromáticos
ES2354390T3 (es) * 2006-04-11 2011-03-14 Arena Pharmaceuticals, Inc. Procedimientos de uso del receptor gpr119 para identificar compuestos útiles para aumentar la masa ósea en un individuo.
PE20071221A1 (es) * 2006-04-11 2007-12-14 Arena Pharm Inc Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
WO2009038974A1 (en) 2007-09-20 2009-03-26 Irm Llc Compounds and compositions as modulators of gpr119 activity
EP2146210A1 (de) 2008-04-07 2010-01-20 Arena Pharmaceuticals, Inc. Verfahren zur Verwendung eines AG-Protein-gekoppelten Rezeptors zur Identifikation von Peptid-YY (PPY)-Sekretagogen sowie Verbindungen zur Behandlung durch PYY modulierter Leiden
AU2011305525B2 (en) 2010-09-22 2016-08-18 Arena Pharmaceuticals, Inc. Modulators of the GPR119 receptor and the treatment of disorders related thereto
AU2016205361C1 (en) 2015-01-06 2021-04-08 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the S1P1 receptor
IL285890B (en) 2015-06-22 2022-07-01 Arena Pharm Inc Slate-free crystal of the arginine salt of (Ar)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-4,3,2,1-tetrahydro-cyclopent[b]indole-3-yl ) acetic acid

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000022131A2 (en) * 1998-10-13 2000-04-20 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human g protein-coupled receptors
ATE366815T1 (de) * 1998-11-20 2007-08-15 Arena Pharm Inc Menschliche, an ein g-protein gekoppelter rezeptor rup3 ohne bekannten ligand
US6221660B1 (en) * 1999-02-22 2001-04-24 Synaptic Pharmaceutical Corporation DNA encoding SNORF25 receptor
GB9923177D0 (en) * 1999-09-30 1999-12-01 Pfizer Ltd Novel polypeptide
EP1226250A2 (de) * 1999-11-03 2002-07-31 MERCK PATENT GmbH Gpcr-kd5 polypeptide und dns sequenzen davon
AU784543B2 (en) * 1999-11-16 2006-04-27 Pharmacia & Upjohn Company Novel G protein-coupled receptors
CA2392961A1 (en) * 1999-12-10 2001-06-14 Incyte Genomics, Inc. G-protein coupled receptors

Also Published As

Publication number Publication date
CY1105966T1 (el) 2011-04-06
AU6744501A (en) 2001-11-26
WO2001087929A3 (en) 2002-05-30
DE60125169D1 (de) 2007-01-25
PT1287133E (pt) 2007-03-30
EP1287133A2 (de) 2003-03-05
WO2001087929A2 (en) 2001-11-22
ES2278755T3 (es) 2007-08-16
DE60125169T2 (de) 2007-11-22
ATE348162T1 (de) 2007-01-15
EP1287133B1 (de) 2006-12-13

Similar Documents

Publication Publication Date Title
DK1287133T3 (da) Regulering af human dopamin-lignende G-protein-koblet receptor
NO20092822L (no) Kjernereseptorbindende midler
MXPA05009524A (es) Derivados de imidazol-4-il-etinil-piridina.
WO2001092297A3 (en) Regulation of human lgr4-like g protein-coupled receptor
WO2002038760A3 (en) Regulation of human extracellular calcium-sensing g protein-coupled receptor
WO2005014797A3 (en) P16 mediated regulation of nmda receptors
WO2001088127A3 (en) Regulation of human follicle stimulating hormone-like g protein-coupled receptor
WO2001092296A3 (en) Regulation of human isotocin-like g protein-coupled receptor
WO2002028898A3 (en) Regulation of human secretin receptor-like gpcr
ATE394487T1 (de) Menschlicher g-protein gekoppelter rezeptor
WO2002029050A3 (en) Regulation of human secretin receptor-like gpcr
WO2002000701A3 (en) Regulation of human gonadotropin releasing hormone receptor-like g protein-coupled receptor
WO2002029052A3 (en) Regulation of human secretin receptor-like gpcr
IL165946A0 (en) Potassium channel sub-units their preparation and use
WO2002029051A3 (en) Human secretin receptor-like gpcr
WO2001088126A8 (en) REGULATION OF HUMAN α1Α ADRENERGIC RECEPTOR-LIKE G PROTEIN-COUPLED RECEPTOR
WO2002059302A3 (en) Regulation of human serotonin-like g protein-coupled receptor
WO2001068702A3 (en) Regulation of human g protein-coupled receptor
SI1753757T1 (sl) Substituirani 2,5-diaminometil-1H-piroli
WO2004099248A3 (en) Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor agtr2 (agtr2)
WO2002042435A3 (en) Regulation of human tyrosine phosphatase
WO2002099107A3 (en) Regulation of human trace amine receptor ta5
WO2003000903A3 (en) Regulation of human nek-like serine/threonine protein kinase
WO2005040790A3 (en) Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 75 (gpr75)
WO2004038407A3 (en) Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 12 (gpr12)